ABRAXANE®: New Hope for Non-Small Cell Lung Cancer
ABRAXANE®, drug has been approved by U.S. Food and Drug Administration (FDA) for non-small cell lung cancer as a paclitaxel Protein-bound injectable particles. ABRAXANE® is a product by Celgene, an...
View ArticleKasabach–Merritt Syndrome-Hemangioma
Kasabach–Merritt syndrome commonly known as Hemangioma with thrombocytopenia. This syndrome is generally affected by a vascular tumour, regularly occurs from birth or hemangioendothelioma. It can be...
View Article
More Pages to Explore .....